Skip to main content
Sign In

 

CONTACT US

Barbara Davis Center for Childhood Diabetes

Cherie Cobb
Executive Administrator
Barbara Davis Center
The Anschutz Medical Campus
Mail Stop B140
1775 Aurora Court
Aurora, CO 80045

Phone: 303-724-2323

Email: Cherie Cobb

Web: barbaradaviscenter.org

Children's Hospital Colorado - www.childrenscolorado.org​​​​​​​
Barbara Davis Center Faculty
 

Barbara Davis Center for Childhood Diabetes

Affiliate - Department of Pediatrics

The Barbara Davis Center for Childhood Diabetes (BDC) is one of the largest diabetes programs specializing in type 1 diabetes research and care (both for children and adults) in the world. The BDC is managed as a distinct administrative unit of the University of Colorado School of Medicine.

In 1978, Marvin Davis generously provided funds for the construction of the BDC building. The Center was opened in 1980 at the former 9th Avenue campus in Denver. In May 2005, the BDC relocated to our new building on the Anschutz Medical Campus in Aurora, Colorado.

Our independent budget, fund raising, and endowments provide unique facilities and resources for clinicians, clinical researchers, and basic biomedical scientists working to help patients with type 1 diabetes. The Center provides state-of-the-art clinical diabetes care to 80% of children with diabetes in Colorado, 2,000 adults within the Rocky Mountain Region, and also receives national and international referrals.

Executive Director: Marian J. Rewers, MD, PhD, MPH
Clinical Division Director: Marian J. Rewers, MD, PhD, MPH
Research Division Director:

On this website you will find overview information from the Department of Pediatrics' Report about research, clinical services, education activities, faculty, recent publications, research funding, and awards and honors for the Barbara Davis Center.

Visit the Barbara Davis Center's own website for further information.

HIGHLIGHTS & NEWS

  • Researchers from the Barbara Davis Center for Childhood Diabetes are featured in the current issue of the Journal of the American Medical Association (JAMA). The international team found that daily dose of insulin resulted in an immune response without hypoglycemia, pointing toward the need for further trials to see if it is possible to develop a vaccine for the disease.
  • In a separate article in the same issue of JAMA, a team of researchers from CU SOM (led by Arleta Rewers, MD, PhD) found an increase in the number of children, who at the time of diagnosis with type 1 diabetes, have diabetic ketoacidosis, a life-threatening complication that involves dangerously high blood sugar and substances in the blood called ketones.
  • John Kappler, PhD, has been named interim scientific director of the Barbara Davis Center for Childhood Diabetes. Kappler also received the George S. Eisenbarth Memorial Award at the Immunology of Diabetes Society 14th International Congress.
  • Dr. Andrea Steck is the recipient of the American Diabetes Association Thomas R. Lee Award for her ADA-funded research project: “Determinants of rate of progression to type 1 diabetes".
  • Dr. Marian Rewers has been named director of the Barbara Davis Center for Childhood Diabetes